351 related articles for article (PubMed ID: 32281186)
21. Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.
Camm AJ; Fox KAA
Open Heart; 2018; 5(1):e000788. PubMed ID: 29713485
[TBL] [Abstract][Full Text] [Related]
22. Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making.
Katkade VB; Sanders KN; Zou KH
J Multidiscip Healthc; 2018; 11():295-304. PubMed ID: 29997436
[TBL] [Abstract][Full Text] [Related]
23. The value of real world evidence: The case of medical cannabis.
Schlag AK; Zafar RR; Lynskey MT; Athanasiou-Fragkouli A; Phillips LD; Nutt DJ
Front Psychiatry; 2022; 13():1027159. PubMed ID: 36405915
[TBL] [Abstract][Full Text] [Related]
24. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
25. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
F1000Res; 2018; 7():111. PubMed ID: 30026923
[TBL] [Abstract][Full Text] [Related]
26. [Evidence of the efficacy and safety of cannabis medicines for chronic pain management : A methodological minefield].
Häuser W; Petzke F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):836-844. PubMed ID: 31139839
[TBL] [Abstract][Full Text] [Related]
27. A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China.
Storm NE; Chang W; Lin TC; Lange JL; Bradbury B; Critchlow CW; Galson SK
Ther Innov Regul Sci; 2022 Jan; 56(1):137-144. PubMed ID: 34633649
[TBL] [Abstract][Full Text] [Related]
28. Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Häuser W; Welsch P; Klose P; Radbruch L; Fitzcharles MA
Schmerz; 2019 Oct; 33(5):424-436. PubMed ID: 31073761
[TBL] [Abstract][Full Text] [Related]
29. Creating and using real-world evidence to answer questions about clinical effectiveness.
de Lusignan S; Crawford L; Munro N
J Innov Health Inform; 2015 Nov; 22(3):368-73. PubMed ID: 26577427
[TBL] [Abstract][Full Text] [Related]
30. Real-World Evidence-Current Developments and Perspectives.
Schad F; Thronicke A
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011793
[TBL] [Abstract][Full Text] [Related]
31. Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain.
Campbell G; Stockings E; Nielsen S
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):135-144. PubMed ID: 30635715
[TBL] [Abstract][Full Text] [Related]
32. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
33. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.
Häuser W; Finn DP; Kalso E; Krcevski-Skvarc N; Kress HG; Morlion B; Perrot S; Schäfer M; Wells C; Brill S
Eur J Pain; 2018 Oct; 22(9):1547-1564. PubMed ID: 30074291
[TBL] [Abstract][Full Text] [Related]
34. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
35. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
[TBL] [Abstract][Full Text] [Related]
36. [Position paper on medical cannabis and cannabis-based medicines in pain medicine].
Petzke F; Karst M; Gastmeier K; Radbruch L; Steffen E; Häuser W;
Schmerz; 2019 Oct; 33(5):449-465. PubMed ID: 31541311
[TBL] [Abstract][Full Text] [Related]
37. Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative.
Orsini LS; Berger M; Crown W; Daniel G; Eichler HG; Goettsch W; Graff J; Guerino J; Jonsson P; Lederer NM; Monz B; Mullins CD; Schneeweiss S; Brunt DV; Wang SV; Willke RJ
Value Health; 2020 Sep; 23(9):1128-1136. PubMed ID: 32940229
[TBL] [Abstract][Full Text] [Related]
38. The Expanding Role of Real-World Evidence Trials in Health Care Decision Making.
Klonoff DC
J Diabetes Sci Technol; 2020 Jan; 14(1):174-179. PubMed ID: 30841738
[TBL] [Abstract][Full Text] [Related]
39. Real-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical Records.
Kim HS; Lee S; Kim JH
J Korean Med Sci; 2018 Aug; 33(34):e213. PubMed ID: 30127705
[TBL] [Abstract][Full Text] [Related]
40. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S
Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
